Видео ютуба по тегу Screen Of Kinase Inhibitors

Targeting Kinases for Drug Discovery
Targeting Kinases for Drug Discovery
Webinar Wednesdays - Tyrosine kinase inhibitors & PKD
Webinar Wednesdays - Tyrosine kinase inhibitors & PKD
Inhibitor Screening to identify Kinases regulating ESC Pluripotency | Protocol Preview
Inhibitor Screening to identify Kinases regulating ESC Pluripotency | Protocol Preview
Highlights From Bruton’s Tyrosine Kinase Inhibitors
Highlights From Bruton’s Tyrosine Kinase Inhibitors
HCC Whiteboard #2: The Mechanisms of Action of Tyrosine Kinase Inhibitors
HCC Whiteboard #2: The Mechanisms of Action of Tyrosine Kinase Inhibitors
Harnessing the Kinome: Multi-Kinase Inhibitors for the Management of Hepatocellular Carcinoma
Harnessing the Kinome: Multi-Kinase Inhibitors for the Management of Hepatocellular Carcinoma
webinar recording: Bruton's Tyrosine Kinase inhibitors: two strategies showcased in SeeSAR
webinar recording: Bruton's Tyrosine Kinase inhibitors: two strategies showcased in SeeSAR
Use of VEGF-Targeted Tyrosine Kinase Inhibitors
Use of VEGF-Targeted Tyrosine Kinase Inhibitors
HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors
HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors
Bruton Tyrosine Kinase Inhibitors
Bruton Tyrosine Kinase Inhibitors
S2E10: The Retina Radar With Dr. Arshad Khanani: Tyrosine Kinase Inhibitors With Dr. Dilsher Dhoot
S2E10: The Retina Radar With Dr. Arshad Khanani: Tyrosine Kinase Inhibitors With Dr. Dilsher Dhoot
Antibody Arrays to Assess resistance to Tyrosine kinase inhibitors | Protocol Preview
Antibody Arrays to Assess resistance to Tyrosine kinase inhibitors | Protocol Preview
Understanding Tropomyosin Receptor Kinase Inhibitors
Understanding Tropomyosin Receptor Kinase Inhibitors
Kinase Inhibitors and Immunomodulatory Drugs - What does the future hold for lymphomas?
Kinase Inhibitors and Immunomodulatory Drugs - What does the future hold for lymphomas?
Mechanisms of resistance to EGFR tyrosine kinase inhibitors | RTCL.TV
Mechanisms of resistance to EGFR tyrosine kinase inhibitors | RTCL.TV
Kinase Inhibitors Antineoplastic Drugs for Cancer
Kinase Inhibitors Antineoplastic Drugs for Cancer
5.6 Drug targets - too many kinases
5.6 Drug targets - too many kinases
Dr. Grigg on Frontline Tyrosine Kinase Inhibitors in RCC
Dr. Grigg on Frontline Tyrosine Kinase Inhibitors in RCC
Emerging data on immunotherapies and tyrosine kinase inhibitors in lung cancer: 2022 ESMO Florida
Emerging data on immunotherapies and tyrosine kinase inhibitors in lung cancer: 2022 ESMO Florida
Anti-PD1 or tyrosine kinase inhibitors?
Anti-PD1 or tyrosine kinase inhibitors?
Human Protein Kinase CK2 Inhibitors: Discovering New Scaffolds
Human Protein Kinase CK2 Inhibitors: Discovering New Scaffolds
e-IDG Symposium Series - Kinase talks by Dr. Jian Jin and Dr. David Drewry on Nov. 4, 2021
e-IDG Symposium Series - Kinase talks by Dr. Jian Jin and Dr. David Drewry on Nov. 4, 2021
Battling Resistance in Tumors with “Pan-Variant” Kinase Inhibitors
Battling Resistance in Tumors with “Pan-Variant” Kinase Inhibitors
Mechanisms of resistance to EGFR tyrosine kinase inhibitors | RTCL.TV
Mechanisms of resistance to EGFR tyrosine kinase inhibitors | RTCL.TV
Eric Vachon on the Effect of Complexity on Adherence with Kinase Inhibitors
Eric Vachon on the Effect of Complexity on Adherence with Kinase Inhibitors